At the start of the pandemic, there was concern that certain drugs for high blood pressure might be linked with worse outcomes for COVID-19 patients.
Sep 23, 2020
0
30
Early in the onset of the COVID-19 pandemic, a small study in China produced results that influenced subsequent research on the virus. Researchers at the University of Cincinnati used the same study parameters on a much larger ...
Sep 17, 2020
0
164
Heart patients hospitalized with COVID-19 can safely continue taking angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs), according to the BRACE CORONA trial presented in a Hot Line session ...
Sep 1, 2020
0
3
Worldwide, 850 million people are affected by chronic kidney disease (CKD)—a worrying figure, and one that continues to rise. Treatment options for patients with CKD are multiple and often determined by the etiology of ...
Aug 31, 2020
0
7
Medication for high blood pressure could improve COVID-19 survival rates and reduce the severity of infection—according to new research from the University of East Anglia.
Aug 24, 2020
1
50
A large-scale analysis of the clinical characteristics of Alport syndrome in Japanese patients has revealed that the effectiveness of existing treatment with ACE inhibitors and/or angiotensin receptor blockers (RAS inhibitors) ...
Aug 7, 2020
0
2
(HealthDay)—More than one-third of stroke survivors have uncontrolled hypertension, and about one in five are not taking antihypertensive medications, according to a study published online July 27 in JAMA Neurology.
Aug 3, 2020
0
6
A new Northwestern Medicine study in mice found a widely used class of drugs to treat patients with hypertension, cardiovascular disease and diabetic kidney disease—many of whom are elderly—does not increase the risk ...
Jul 22, 2020
0
0
Patients with raised blood pressure have a two-fold increased risk of dying from the coronavirus COVID-19 compared to patients without high blood pressure, according to new research published in the European Heart Journal ...
Jun 5, 2020
0
7
A Yale-led study suggests that older COVID-19 patients taking ACE inhibitors for hypertension have a lower risk of hospitalization for the novel coronavirus.
May 28, 2020
0
22
